Www.euronanomed.net E UROpean network of transnational collaborative RTD projects in the field of...

www.euronanomed.net

EUROpean network of transnational collaborative RTD projects

in the field of NANOMEDicine

www.euronanomed.net

What are the societal needs? - the challenge for Europe

Improve public health and welfare– Ageing population– Efficiency of current medical

solutions– Emergence of new disease and old

diseases are back– Personalized medicine future

directions

www.euronanomed.net

The global challenge

• Therapeutic solutions for only 1/3 known diseases (WHO)

• Infections: HIV, TB, malaria, risk of pandemia

• Need to increase capability and innovation of medical industry– Rapid and accurate diagnosis for

early detection, even prevention– Novel, more efficient therapies with

less side effects

www.euronanomed.net

Nano from research to patient and industry

Nanomedicine: the application of nanotechnology to achieve breakthroughs in healthcare

Foto: kaibara87/www.flickr.com

www.euronanomed.net

Emerging nanomedicine

Lancet Infectious Diseases

April issue, vol 9, 2009

www.euronanomed.net

Principle of theERA-net scheme

F

G

UK

ES

DE

CP

CP

CP

CP

CP

Without ERA-Net

Prog

FProg

GProg

UKProg

ESProg

DE

Common transnational dedicated CP

With ERA-Net

…

(CP: Call for projects)

€ : EC supports the coordination costs. Each national programme supports their national partners within the selected projects

www.euronanomed.net

EuroNanoMed covers 3/4 of European

nanomedicine actors

• 24 partners from 18 countries/regions

• Coordination of funding programmes in nanomedicine

• Started January 2009

• EU funding for coordination for coordination ((ERA-net in FP7)

2 common joint calls for proposals 2009, 2010

www.euronanomed.net

EuroNanoMed: an asset to bridge the gap

2 calls to support RTD projects aiming at– solving an unmet medical need using

nanomedicine– promoting a multidisciplinary translational

approach with an international focus

EuroNanoMed will achieve

a critical mass of actors !!!

www.euronanomed.net

EuroNanoMed outputs

• Develop innovative diagnostic and therapeutic solutions for the patient, enhancing the competitiveness of the European health industry

• Maturation of the field To bring together – academic teams – clinical/public health teams– industrial research teams

• Cross-border collaboration between the best researchers/teams in nanomedicine

www.euronanomed.net

Why now? What’s the urgency?

• Health industry: a key for future growth

• European countries invest substantially in nano industry and basic nano research

• Nano technologies: a promising field for innovation and patient application

Despite these efforts, Europe is lagging behind the US in an increasing competition :

Europe needs to act now!

www.euronanomed.net

Expected outcome

• To move innovation from knowledge to industrial technology and health care applications

• Opening the national programmes to support transnational RTD partnerships

Long term vision: formula for an European-

wide integrated programme with a coordinated funding

www.euronanomed.net

Contacts

• CoordinatorDr. Pierre-Noël LIRSAC Commissariat à l’Energie Atomique (CEA)Pierre-noel.lirsac@cea.fr, Virginie.sivan@cea.fr (+33) 1 69 08 87 99

• Network Steering Committee chair Associate Prof. Karin Forsberg-NilssonSwedish research Council (SRC)

Karin.forsberg.nilsson@vr.se

www.euronanomed.net

EuroNanoMed ERA

Networking towards ERA!

www.euronanomed.net

EuroNanoMed First joint transnational call

for proposals

18 partners

16 countries/regions

www.euronanomed.net

Funding organisations in the first call for proposals• Industry, Trade and Tourism Department, Basque Government (ITT), Basque region (Spain)• Swiss National Science Foundation (SNSF), Switzerland• VDI Technologiezentrum GmbH, Germany• Instituto de Salud Carlos III (ISCIII), Spain • The French National Research Agency (ANR), France• The Chief Scientist Office, The Ministry of Health (CSO-MOH), Israel• The Icelandic Centre for Research (RANNIS), Iceland• The Latvian Academy of Sciences (LAS), Latvia• SenterNovem, The Netherlands• National Centre for Research and Development (NCBiR), Poland• Fundacao para a Ciencia e a Tecnologia (FCT), Portugal• National Center for Programme Management (CNMP), Romania• The Swedish Research Council (SRC)(Vetenskapsrådet), Sweden• The Swedish Governmental Agency for Innovation Systems (VINNOVA ), Sweden• The Scientific and Technological Research Council of Turkey (TUBITAK), Turkey• Science Council of Lithuania (LSC), Lithuania• Economic development, research and innovation Directorate, Veneto region (Italy)• Public Service of Wallonia: Operational General Directorate for Economy, Employment,

and Research (DGOEER), Walloon Region (Belgium)

www.euronanomed.net

Topics

• Diagnostics

• Targeted drug delivery

• Regenerative medicine

www.euronanomed.net

Aim of the 1st call for proposals

• To find new medical solutions

• To enable an effective multi-national collaboration on research projects– Promoting multidisciplinary efforts– Encouraging translational research proposals that

combine either basic/clinical and/or industrial approach

– Having an added value in funding the transnational collaboration over the individual projects

• To support novel, ambitious ideas and possibility of application to end users

www.euronanomed.net

Eligibility criteria

Consortia with room for flexibility– 3 -7 partners from at least three partnering countries

– At least one clinical/public health research team and/or one industrial research team per consortium

– At least two categories (academic/clinical/industrial teams)

– Project consortium partners´ eligibility depends upon national regulation

www.euronanomed.net

Funding, 1st call

• Indicative total funding 15-20 M€

• Funding for up to 3 years

• Selected projects receive funding directly from their corresponding national/regional funding bodies after meeting their national regulations

www.euronanomed.net

Time lines, 1st call

• Call opens: End of May 2009

• Call closes: September 1st 2009

• Funding decision: December 2009

www.euronanomed.net

For more information

• EuroNanoMed Call officeVeneto Nanotech s.c.p.a.

Via San Crispino, 10635129 Padova – Italy 

: +39 049 7705520

email: calloffice@euronanomed.netwebsite: www.euronanomed.net

• National/regional contacts

www.euronanomed.net

Together we're building nanomedicine for the future!